A short-activating RNA oligonucleotide targeting the islet β-cell transcriptional factor MafA in CD34+ cells

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages

  Reebye, Vikash ^a   Sætrom, Pål ^b   Mintz, Paul J ^a   Rossi, John J ^c   Kasahara, Noriyuki ^d   Nteliopoulos, Georgios ^e   Nicholls, Joanna ^a   Haoudi, Abdelali ^f   Gordon, Myrtle ^e   Habib, Nagy A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOKINASE; INSULIN; MUSCULOAPONEUROTIC FIBROSARCOMA A PROTEIN; NEUROGENIN 3; RNA; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL SELECTION; CONTROLLED STUDY; DRUG TARGETING; ENDODERM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INSULIN RELEASE; INSULIN SYNTHESIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RNA TRANSCRIPTION; SINGLE CELL ANALYSIS; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 84878870592     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2013.23     Document Type: Article

References (52)

1. American Diabetes Association. (2011). Standards of medical care in diabetes-2011. Diabetes Care 34: S11-61.
2. Chen, S, Ding, J, Yu, C, Yang, B, Wood, DR and Grayburn, PA (2007). Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Ther 14: 1102-1110. (Pubitemid 47029493)
3. Shapiro, AM, Lakey, JR, Ryan, EA, Korbutt, GS, Toth, E, Warnock, GL et al. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343: 230-238. (Pubitemid 30490390)
4. Assady, S, Maor, G, Amit, M, Itskovitz-Eldor, J, Skorecki, KL and Tzukerman, M (2001). Insulin production by human embryonic stem cells. Diabetes 50: 1691-1697. (Pubitemid 33641584)
5. Lumelsky, N, Blondel, O, Laeng, P, Velasco, I, Ravin, R and McKay, R (2001). Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292: 1389-1394. (Pubitemid 32476228)
6. Lechner, A, Nolan, AL, Blacken, RA and Habener, JF (2005). Redifferentiation of insulinsecreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem Biophys Res Commun 327: 581-588. (Pubitemid 40040514)
7. Yatoh, S, Dodge, R, Akashi, T, Omer, A, Sharma, A, Weir, GC et al. (2007). Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes 56: 1802-1809. (Pubitemid 47025448)
8. Elsner, M, Jorns, A and Lenzen, S (2008). Diabetes therapy by lentiviral hepatic insulin gene expression without transformation of liver. Diabetologia 51: 694-5; author reply 696.
9. Talchai, C, Xuan, S, Kitamura, T, Depinho, RA and Accili, D (2012). Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat Genet (doi:10.1038/ng.2215).
10. Ianus, A, Holz, GG, Theise, ND and Hussain, MA (2003). In vivo derivation of glucosecompetent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843-850. (Pubitemid 37074959)
11. Hebrok, M, Kim, SK and Melton, DA (1998). Notochord repression of endodermal Sonic hedgehog permits pancreas development. Genes Dev 12: 1705-1713. (Pubitemid 28299520)
12. D'Amour, KA, Bang, AG, Eliazer, S, Kelly, OG, Agulnick, AD, Smart, NG et al. (2006). Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 24: 1392-1401. (Pubitemid 44722103)
13. Pittenger, MF, Mackay, AM, Beck, SC, Jaiswal, RK, Douglas, R, Mosca, JD et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
14. Jensen, J, Pedersen, EE, Galante, P, Hald, J, Heller, RS, Ishibashi, M et al. (2000). Control of endodermal endocrine development by Hes-1. Nat Genet 24: 36-44. (Pubitemid 30041417)
15. Nakhai, H, Siveke, JT, Klein, B, Mendoza-Torres, L, Mazur, PK, Algul, H et al. (2008). Conditional ablation of Notch signaling in pancreatic development. Development 135: 2757-2765.
16. Smith, SB, Qu, HQ, Taleb, N, Kishimoto, NY, Scheel, DW, Lu, Y et al. (2010). Rfx6 directs islet formation and insulin production in mice and humans. Nature 463: 775-780.
17. Aguayo-Mazzucato, C, Koh, A, El Khattabi, I, Li, WC, Toschi, E, Jermendy, A et al. (2011). Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells. Diabetologia 54: 583-593.
18. Jiang, J, Au, M, Lu, K, Eshpeter, A, Korbutt, G, Fisk, G et al. (2007). Generation of insulinproducing islet-like clusters from human embryonic stem cells. Stem Cells 25: 1940-1953. (Pubitemid 47258172)
19. Cho, YM, Lim, JM, Yoo, DH, Kim, JH, Chung, SS, Park, SG et al. (2008). Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic beta-cell differentiation in human embryonic stem cells. Biochem Biophys Res Commun 366: 129-134. (Pubitemid 350297223)
20. Shim, JH, Kim, SE, Woo, DH, Kim, SK, Oh, CH, McKay, R et al. (2007). Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 50: 1228-1238. (Pubitemid 46701546)
21. Fujikawa, T, Oh, SH, Pi, L, Hatch, HM, Shupe, T and Petersen, BE (2005). Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cellderived insulin-producing cells. Am J Pathol 166: 1781-1791. (Pubitemid 40734401)
22. Roobrouck, VD, Vanuytsel, K and Verfaillie, CM (2011). Concise review: culture mediated changes in fate and/or potency of stem cells. Stem Cells 29: 583-589.
23. Chandra, V, Swetha, G, Muthyala, S, Jaiswal, AK, Bellare, JR, Nair, PD et al. (2011). Isletlike cell aggregates generated from human adipose tissue derived stem cells ameliorate experimental diabetes in mice. PLoS ONE 6: e20615.
24. Kim, JH, Shin, KH, Li, TZ and Suh, H (2011). Potential of nucleofected human MSCs for insulin secretion. J Tissue Eng Regen Med 5: 761-769.
25. Limbert, C, Päth, G, Ebert, R, Rothhammer, V, Kassem, M, Jakob, F et al. (2011). PDX1-and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages. Cytotherapy 13: 802-813.
26. Paz, AH, Salton, GD, Ayala-Lugo, A, Gomes, C, Terraciano, P, Scalco, R et al. (2011). Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats. Stem Cells Dev 20: 223-232.
27. Yuan, H, Li, J, Xin, N, Zhao, Z and Qin, G (2010). Expression of Pdx1 mediates differentiation from mesenchymal stem cells into insulin-producing cells. Mol Biol Rep 37: 4023-4031.
28. Chang, CF, Hsu, KH, Chiou, SH, Ho, LL, Fu, YS and Hung, SC (2008). Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells. J Biomed Mater Res A 86: 1097-1105.
29. Lin, HY, Tsai, CC, Chen, LL, Chiou, SH, Wang, YJ and Hung, SC (2010). Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK. J Biomed Sci 17: 56.
30. Tang, XL, Xiao, R, Wang, YX, He, M, Xie, T, Zhang, C et al. (2011).[Neurogenin 3 and Paired box gene 4 promote PDX1-induced differentiation of mesenchymal stem cells into pancreatic secretory cells]. Beijing Da Xue Xue Bao 43: 421-426.
31. Wang, HW, Lin, LM, He, HY, You, F, Li, WZ, Huang, TH et al. (2011). Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulinproducing cells in vitro. Chin Med J 124: 1534-1539.
32. Li, LC, Okino, ST, Zhao, H, Pookot, D, Place, RF, Urakami, S et al. (2006). Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA 103: 17337-17342. (Pubitemid 44788970)
33. Janowski, BA, Younger, ST, Hardy, DB, Ram, R, Huffman, KE and Corey, DR (2007). Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol 3: 166-173.
34. Huang, V, Qin, Y, Wang, J, Wang, X, Place, RF, Lin, G et al. (2010). RNAa is conserved in mammalian cells. PLoS ONE 5: e8848.
35. Morris, KV, Santoso, S, Turner, AM, Pastori, C and Hawkins, PG (2008). Bidirectional transcription directs both transcriptional gene activation and suppression in human cells. PLoS Genet 4: e1000258.
36. Schwartz, JC, Younger, ST, Nguyen, NB, Hardy, DB, Monia, BP, Corey, DR et al. (2008). Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol 15: 842-848.
37. Modarresi, F, Faghihi, MA, Lopez-Toledano, MA, Fatemi, RP, Magistri, M, Brothers, SP et al. (2012). Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation. Nat Biotechnol 30: 453-459.
38. Gordon, MY (2008). Stem cells for regenerative medicine-biological attributes and clinical application. Exp Hematol 36: 726-732.
39. Gordon, MY, Levicar, N, Pai, M, Bachellier, P, Dimarakis, I, Al-Allaf, F et al. (2006). Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 24: 1822-1830. (Pubitemid 44474196)
40. Voutila, J, Sætrom, P, Mintz, P, Sun, G, Alluin, J, Rossi, JJ et al. (2012). Gene Expression Profile Changes After Short-activating RNA-mediated Induction of Endogenous Pluripotency Factors in Human Mesenchymal Stem Cells. Mol Ther Nucleic Acids 1: e35.
41. Laub, O, Rall, L, Bell, GI and Rutter, WJ (1983). Expression of the human insulin gene in an alternate mammalian cell and in cell extracts. J Biol Chem 258: 6037-6042.
42. Zhukova, E, Afshar, A, Ko, J, Popper, P, Pham, T, Sternini, C et al. (2001). Expression of the human insulin gene in the gastric G cells of transgenic mice. Transgenic Res 10: 329-341. (Pubitemid 32835835)
43. Kawai, S, Mukai, T, Mori, S, Mikami, B and Murata, K (2005). Hypothesis: structures, evolution, and ancestor of glucose kinases in the hexokinase family. J Biosci Bioeng 99: 320-330. (Pubitemid 40740581)
44. Toft-Nielsen, MB, Madsbad, S and Holst, JJ (2001). Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J Clin Endocrinol Metab 86: 3853-3860. (Pubitemid 32755988)
45. Aguilar-Bryan, L, Nichols, CG, Wechsler, SW, Clement, JP 4th, Boyd, AE 3rd, González, G et al. (1995). Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268: 423-426.
46. Nichols, CG, Shyng, SL, Nestorowicz, A, Glaser, B, Clement, JP 4th, Gonzalez, G et al. (1996). Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272: 1785-1787. (Pubitemid 26256397)
47. Wasmeier, C and Hutton, JC (1999). Secretagogue-dependent phosphorylation of phogrin, an insulin granule membrane protein tyrosine phosphatase homologue. Biochem J 341 (Pt 3): 563-569. (Pubitemid 29389185)
48. Wang, H, Brun, T, Kataoka, K, Sharma, AJ and Wollheim, CB (2007). MAFA controls genes implicated in insulin biosynthesis and secretion. Diabetologia 50: 348-358.
49. Aramata, S, Han, SI and Kataoka, K (2007). Roles and regulation of transcription factor MafA in islet beta-cells. Endocr J 54: 659-666. (Pubitemid 351377742)
50. Beck, J, Angus, R, Madsen, B, Britt, D, Vernon, B and Nguyen, KT (2007). Islet encapsulation: strategies to enhance islet cell functions. Tissue Eng 13: 589-599. (Pubitemid 46579884)
51. Ludwig, B, Rotem, A, Schmid, J, Weir, GC, Colton, CK, Brendel, MD et al. (2012). Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci USA 109: 5022-5027.
52. Saetrom, P and Snove, O Jr (2004). A comparison of siRNA efficacy predictors. Biochem Biophys Res Commun 321: 247-253. (Pubitemid 39055631)